Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Pancragen and BAC Water Mix

Pancragen Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Pancragen Titration Schedule

ItemDetails
Standard dose50 mcg daily ×10 days (research); 10 mg ×10 days (Khavinson human tradition)
Courses10–20 days, 2–3× per year
Originator dose10–1000× lower (Russian tradition)

Primate data: 50 mcg/day corrected impaired glucose tolerance, effect lasting 3 weeks. Zero controlled human trials. The '1–5 mg per dose' figure is a recurring placeholder that never matched a validated protocol for any bioregulator; sources disagree up to 1000× on real doses.

Possible vial strengths:

What Is It?

Pancragen

Pancreatic short peptide bioregulator.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Pancragen

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Pancragen Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Pancragen is a Khavinson "bioregulator" — a short tetrapeptide (Lys-Glu-Asp-Trp, ~576 Da) originally derived from pancreatic tissue and developed in Russia to support pancreatic function. It comes in two very different forms: an oral capsule sold as a dietary supplement, and a research-grade injectable powder sold for laboratory use. The proposed idea is that this tiny peptide reaches pancreatic cells and influences how they regulate glucose.
No — these are completely unrelated despite the near-identical spelling. PancraGEN (Interpace Diagnostics) is a DNA-based lab test that analyzes pancreatic cyst fluid for cancer-risk gene mutations like KRAS and TP53; it is a diagnostic, not a peptide, and nothing about it is reconstituted or injected. Note also that Interpace stopped accepting specimens for that test in May 2025. If you're looking for the cyst-fluid cancer test, this reconstitution page isn't it.
The headline studies are from Khavinson's group: in aged monkeys, Pancragen reportedly improved glucose tolerance and normalized insulin, and a small Russian trial used an oral 500 mcg dose in elderly prediabetic patients. Mechanistically it's described as acting on pancreatic gene expression, turning up cell-maturation transcription factors. Importantly, this body of evidence is largely Russian and not independently confirmed in Western trials — Pancragen is not a treatment for diabetes and shouldn't replace one.
Only one of the two forms is reconstituted: the oral capsule is swallowed and never mixed, while the research-grade injectable powder is the one you reconstitute. For that powder the math is standard — a 20 mg vial + 4 mL bacteriostatic water = 5 mg/mL, so a 500 mcg amount = 0.1 mL (10 units on a U-100 syringe). Keep in mind the only human clinical dosing was oral (500 mcg twice daily); an injectable human dose isn't established.
Pancragen has no FDA approval — the oral version is sold as a dietary supplement and the injectable as a research-only compound, neither tested to drug standards. Reported side effects from user protocols are mild (transient fatigue, headache, minor GI changes), but there is no rigorous Western safety data, and anyone with a real pancreatic or glucose disorder needs proper medical care, not a supplement. Storage: keep capsules cool and dry; store the lyophilized injectable powder refrigerated and protected from light, and use any reconstituted solution promptly.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides